Amylyx Pharmaceuticals to Present Topline Data for Avexitide Trial

Amylyx Pharmaceuticals announced it will present topline results from its Phase 3 LUCIDITY clinical trial of avexitide in post-bariatric hypoglycemia at the ObesityWeek® 2026 Annual Meeting.